![Dae-Kwon Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 11 M $ op 30-06-2026
Dae-Kwon Kim currently works at Voronoi, Inc., as Co-Chief Executive Officer, Director, Head-R&D.
Dr. Kim received his undergraduate degree and graduate degree from Seoul National University and doctorate degree from Kyungpook National University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VORONOI, INC. 0,48% | 03-07-2026 | 88.050 ( 0,48% ) | 11 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VORONOI, INC. | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyungpook National University
 Kyungpook National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voronoi, Inc.
 Voronoi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures novel kinase inhibitors and target protein degrader drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
